Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study

Clinical trial NCT02960997 · COMPLETED

Trial details

NCT number: NCT02960997
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Epidermolysis Bullosa Simplex Epidermolysis Bullosa Simplex Kobner Weber-Cockayne Syndrome

Start date: 2016-05-01
Primary completion: 2018-12-14
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.